Back to Market Feed

Product Information

VANCOMYCIN HCL 5 GM VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $39.3160 per EA under NDC 00143916301. Its NADAC has been published 52 times since Sep 18, 2024.

FDA first approved this application on Jan 20, 2023.

VANCOMYCIN HCL 5 GM VIAL

vancomycin hydrochloride
$39.3160per EA

Strength

5.13 g/g

NDC

00143916301

Classification

Generic

Dosage Form

INJECTION, POWDER, FOR SOLUTION

Route

INTRAVENOUS; ORAL

Effective Date

9/18/2024

Active Ingredients

VANCOMYCIN HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA210274

FDA Approved

1/20/2023

On Market Since

2/3/2023

Pharmacological Classes

Glycopeptide Antibacterial
Glycopeptides

Price Statistics

The NADAC for VANCOMYCIN HCL 5 GM VIAL has been published 52 times since Sep 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$39.3160 per EA
All-time high$39.3160 (Sep 10, 2025)
All-time low$39.3160 (Sep 18, 2024)
52-week high$39.3160
52-week low$39.3160
Median price$39.3160
Average price$39.3160
Largest weekly change0.0% (Sep 25, 2024)
Weeks tracked52
Tracking sinceSep 18, 2024

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

0.0%

3Y

N/A

5Y

N/A

All

0.0%

Last surveyed Sep 10, 2025 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the vancomycin hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

VANCOMYCIN 250 MG/5 ML ORAL SOL
Generic
62559083055•ANI Pharmaceuticals, Inc.
$0.7416
per ML
VANCOMYCIN 250 MG/5 ML ORAL SOL
Generic
69238226107•Amneal Pharmaceuticals NY LLC
$0.7416
per ML
VANCOMYCIN 250 MG/5 ML ORAL SOL
Generic
62559083003•ANI Pharmaceuticals, Inc.
$0.8007
per ML
VANCOMYCIN 250 MG/5 ML ORAL SOL
Generic
69238226105•Amneal Pharmaceuticals NY LLC
$0.8007
per ML
VANCOMYCIN HCL 125 MG CAPSULE
Generic
68180016613•Lupin Pharmaceuticals Inc.
$1.4207
per EA
VANCOMYCIN HCL 250 MG CAPSULE
Generic
68180016713•Lupin Pharmaceuticals Inc.
$1.9925
per EA
VANCOMYCIN 500 MG VIAL
Generic
00409433201•Hospira Inc.
$2.3054
per EA
VANCOMYCIN 500 MG VIAL
Generic
31722021010•Camber Pharmaceuticals Inc.
$2.3054
per EA
VANCOMYCIN 500 MG VIAL
Generic
67457033950•Mylan Institutional LLC
$2.3054
per EA
VANCOMYCIN 500 MG VIAL
Generic
70436002082•Slate Run Pharmaceuticals LLC
$2.3054
per EA

Frequently asked questions

What is the NADAC price of VANCOMYCIN HCL 5 GM VIAL?

The current National Average Drug Acquisition Cost (NADAC) for VANCOMYCIN HCL 5 GM VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $39.3160 per EA (NDC 00143916301), effective Sep 10, 2025.

How has the price of VANCOMYCIN HCL 5 GM VIAL changed over time?

Over the history we have for it, the NADAC for VANCOMYCIN HCL 5 GM VIAL has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since Sep 18, 2024.

What are the highest and lowest recorded NADAC prices for VANCOMYCIN HCL 5 GM VIAL?

Since Sep 18, 2024, the NADAC for VANCOMYCIN HCL 5 GM VIAL has ranged from a low of $39.3160 (Sep 18, 2024) to a high of $39.3160 (Sep 10, 2025), with a median of $39.3160 per EA.

Are there cheaper alternatives to VANCOMYCIN HCL 5 GM VIAL?

No other NADAC-published product currently shares the active ingredient and strength of VANCOMYCIN HCL 5 GM VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures VANCOMYCIN HCL 5 GM VIAL?

VANCOMYCIN HCL 5 GM VIAL (NDC 00143916301) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.